Literature DB >> 445330

Therapy-related leukemia: a panmyelosis.

K Foucar, R W McKenna, C D Bloomfield, T K Bowers, R D Brunning.   

Abstract

Fifteen patients developed acute nonlymphocytic leukemia (ANLL) 31 to 182 months following chemotherapy and/or radiotherapy for various malignancies and one non-neoplastic disorder. The ANLL was commonly heralded by a brief preleukemic phase consisting of cytopenias and a variety of morphologic abnormalities. At diagnosis of ANLL, all of the patients had a panmyelosis with variation in the predominant abnormal cell line. Neutrophilic and erythroid abnormalities were most striking in 12 of the patients, megakaryocytic abnormalities predominated in 2 and monocytic abnormalities in 1. Pancytopenia, marked anisopoikilocytosis, normoblastemia, large hypogranular platelets, hypogranular neutrophils, pseudo-Pelger-Huet nuclei, low myeloblast counts and basophilia were the most common abnormalities in the blood. Bone marrows were hypercellular with increased myeloblasts and basophils, abnormal neutrophil precursors, occasional monocytoid blasts, dyserythropoiesis with PAS positive erythroblasts, ring sideroblasts and micromegakaryocytes. All of the 7 patients who had bone marrow chromosome studies exhibited major chromosomal abnormalities. Response to anti-leukemic therapy was poor. The morphologic and clinical findings of these 15 patients appear to define a clinical-pathologic entity.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 445330     DOI: 10.1002/1097-0142(197904)43:4<1285::aid-cncr2820430416>3.0.co;2-j

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  Synergistic action of the benzene metabolite hydroquinone on myelopoietic stimulating activity of granulocyte/macrophage colony-stimulating factor in vitro.

Authors:  R D Irons; W S Stillman; D B Colagiovanni; V A Henry
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

2.  Treatment of therapy-induced preleukemic syndrome.

Authors:  M Gyger; C Perreault; J Carnot; J Boileau; Y Bonny
Journal:  Blut       Date:  1984-02

3.  Myelosuppression in polycythemia vera: chemotherapy or radiotherapy?

Authors:  Y Najean; C Dresch
Journal:  Blut       Date:  1982-01

4.  Tolerance of hemopoiesis for repeated cytotoxic drug therapy.

Authors:  H P Lohrmann
Journal:  Blut       Date:  1979-10

Review 5.  The iatrogenic leukaemias induced by radio- and/or chemotherapy.

Authors:  Y Najean
Journal:  Med Oncol Tumor Pharmacother       Date:  1987

Review 6.  Acute myeloid leukemia in the elderly: biological features and search for adequate treatment.

Authors:  V Heinemann; U Jehn
Journal:  Ann Hematol       Date:  1991-10       Impact factor: 3.673

7.  Acute nonlymphocytic leukemia following bladder instillations with thiotepa.

Authors:  D J Easton; M A Poon
Journal:  Can Med Assoc J       Date:  1983-09-15       Impact factor: 8.262

Review 8.  Myelodysplastic syndromes: their history, evolution and relation to acute myeloid leukaemia.

Authors:  D M Layton; G J Mufti
Journal:  Blut       Date:  1986-12

9.  Survival in acute non-lymphocytic leukaemia following breast cancer.

Authors:  S D Kaster; F F Holmes
Journal:  J R Soc Med       Date:  1990-11       Impact factor: 18.000

Review 10.  Chemical carcinogens: a review of the science and its associated principles. U.S. Interagency Staff Group on Carcinogens.

Authors: 
Journal:  Environ Health Perspect       Date:  1986-08       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.